Allergology

f427 - rAra h 9 (Peanuts)

Test details

This test is useful when a peanut allergy is suspected, LTP cross-reactivity, and to identify the specific molecule that has previously caused a positive result in the associated allergen extract test.
Ara h 9 is a non-specific lipid transfer protein (nsLTP) present in the peanut allergen.
In addition to symptoms associated with oral allergy syndromes, individuals sensitised to Ara h 9 are at greater risk of systemic symptoms and bronchospasm.
The diagnostic accuracy for peanut allergy of anti-Ara h 9 IgEs is limited due to cross-reactivity among LTPs; however, they can be useful in diagnosing allergic symptoms caused by cross-reactions with other LTPs found in pollen and fruit.

Sample type

Serum

Method

ChLIA

Preparation

Fasting for at least 8-12 hours before sampling

Storage conditions

Refer to the Health Service Charter to check storage conditions

Shipping

+2/+8°C

References

Hamilton RG. Allergic sensitization is a key risk factor for but not synonymous with allergic disease. J Allergy Clin Immunol. 2014 Aug;134(2):360-1. doi: 10.1016/j.jaci.2014.02.022. Epub 2014 Mar 31. PMID: 24698318.

Matricardi PM, Kleine-Tebbe J, Hoffmann HJ, Valenta R, Hilger C, et al. EAACI Molecular Allergology User's Guide. Pediatr Allergy Immunol. 2016 May;27 Suppl 23:1-250. doi: 10.1111/pai.12563. PMID: 27288833.

analisi anticorpi anti recettore dell'acetilcolina (AChR) - Laboratorio Euroimmun
analisi anticorpi anti recettore

laboratory analysis

Find other tests

Total tau

This test provides the quantitative determination of total tau protein to support the diagnosis of Alzheimer’s disease.

Phosphorylated Tau (pTau181)

This test provides the quantitative determination of tau protein phosphorylated at threonine 181 (pTau181), to support the diagnosis of Alzheimer’s disease.

Anti–NMDAR Antibodies

Test for the determination of human autoantibodies against NMDAR to support the diagnosis of paraneoplastic neurological syndromes with an intermediate-risk phenotype.

Discover what’s new

Subscribe to the newsletter

Subscribe to our newsletter to be always updated.

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.